Collaboration to harness KSM’s biobank — Israel’s largest and one of the most comprehensive in the world
Boston, September 19, 2022 /PRNewswire/ — Kahn-Sagol-Maccabi (KSM), Research and Innovation Center Israeli Leading HMO – Maccabi Healthcare Services and Valo Health, Inc. (“Valo”), a technology company focused on transforming the drug discovery and development process using human-centric data and artificial intelligence, today announced , launched the first product of its kind. A multi-year collaboration between Valo and Maccabi KSM Research and Innovation’s Biobank to jointly conduct research powered by Valo’s Opal Computational Platform™ to identify preventative and personalized medicine for patients.
Shown above: The collaboration agreement was signed at the office of Maccabi Healthcare Services (from right) by Dr. Tal Patalon, Director of the KSM Research and Innovation Center. Ran Saar, Chairman of Maccabi Healthcare Services. Morris Khan, President Director of KSM. (On screen) David Berry, Founder and CEO of Valo Health. (On screen) Chief of Valo Health Brett Blackman, his Innovation Officer and Head of Corporate Business Development. Sami Sagol, KSM Board President, and Maya Adulamy, Valo Head of Israel.
Valo’s collaboration with KSM’s Biobank, Israel’s largest and one of the world’s most comprehensive and rich datasets, will help analyze complex diseases, identify relationships between diseases, and It is expected to lead to groundbreaking research that predicts new subpopulations within our current knowledge. Using Valo’s Opal platform to generate new insights into disease treatment and prevention. KSM’s Biobank contains her over 800,000 anonymized biological samples of Maccabi member volunteers who have agreed to participate in the Biobank project to advance genetic research.
“Valo is honored to begin this unique collaboration with Maccabi KSM,” said Valo’s Founder and CEO. David BerryAs a leader in fully integrating and leveraging patient data with AI-powered computational power, Valo is committed to identifying and treating complex diseases early and identifying insights to support better treatment decisions. and is in a position to create significant value for Maccabi patients. “
“This collaboration provides an opportunity to link genetic information to medical files, enabling a range of studies that will yield insights into human disease beyond what is known today. Tal Patalon, Head of KSM. “The goal is to make a leap forward in medical innovation and personalized medicine.”
About Khan Sagor Makcabi (KSM):
Kahn-Sagol-Maccabi (KSM) is the research and innovation center of Maccabi Healthcare Services. Israeli Top notch HMO. KSM has unique access to Maccabi’s professional competence and medical knowledge, including his extensive database of 2.5 million members from 30 years of data collection. For more information, see: www.ksminnovation.com.
About Valo Health:
Valo Health, Inc. (“Valo”) is a technology company founded to transform the drug discovery and development process using human-centric data and artificial intelligence-driven computation. As a digitally native company, Valo aims to fully integrate human-centric data across the drug development lifecycle into a single unified architecture. This accelerates the discovery and development of life-changing medicines while reducing cost, time and failure rates. The company’s Opal Computational Platform™ is an integrated set of capabilities designed to transform data into valuable insights, accelerating discovery and empowering Valo with programs across cardiometabolic, nephrology, oncology, and neurodegenerative diseases. enable a robust pipeline of Founded by Flagship Pioneering and headquartered in Boston, Massachusettsalso has an office in Vallo San Francisco, California, new york, new york, Lexington, MassachusettsWhen Branford, ConnecticutFor more information, please visit the following URL: www.valohealth.com.
contact address:
media: Jennifer HanleyVice President of Corporate Communications [email protected] valohealth.com
Investor: Graham Bell,CFO [email protected] BaroHealth.Com
Source Valo Health, Inc.
